Accurate germline RUNX1 variant interpretation and its clinical significance

Simone Feurstein; Liying Zhang; Courtney D. DiNardo

doi:10.1182/bloodadvances.2020003304

Accurate germline RUNX1 variant interpretation and its clinical significance

Simone Feurstein, Liying Zhang, Courtney D. DiNardo

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	6199-6203
Number of pages	5
Journal	Blood Advances
Volume	4
Issue number	24
DOIs	https://doi.org/10.1182/bloodadvances.2020003304
State	Published - Dec 22 2020
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2020003304

Cite this

@article{f76c2395b963442cb39b9b2911ff556a,

title = "Accurate germline RUNX1 variant interpretation and its clinical significance",

author = "Simone Feurstein and Liying Zhang and DiNardo, {Courtney D.}",

note = "Funding Information: Acknowledgments: This work was supported by the National Human Genome Research Institute National Institutes of Health (grants U41HG009649 and U41HG009650) and a 2018 National Institutes of Health/National Cancer Institute Leukemia SPORE DRP award (P50CA100632-16, project 00007529) (C.D.D.). The results provided in this publication were generated by the American Society of Hematology in collaboration with Baylor College of Medicine and the University of North Carolina, National Institutes of Health–funded ClinGen grant award recipients.",

year = "2020",

month = dec,

day = "22",

doi = "10.1182/bloodadvances.2020003304",

language = "English (US)",

volume = "4",

pages = "6199--6203",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "24",

}

TY - JOUR

T1 - Accurate germline RUNX1 variant interpretation and its clinical significance

AU - Feurstein, Simone

AU - Zhang, Liying

AU - DiNardo, Courtney D.

N1 - Funding Information: Acknowledgments: This work was supported by the National Human Genome Research Institute National Institutes of Health (grants U41HG009649 and U41HG009650) and a 2018 National Institutes of Health/National Cancer Institute Leukemia SPORE DRP award (P50CA100632-16, project 00007529) (C.D.D.). The results provided in this publication were generated by the American Society of Hematology in collaboration with Baylor College of Medicine and the University of North Carolina, National Institutes of Health–funded ClinGen grant award recipients.

PY - 2020/12/22

Y1 - 2020/12/22

UR - http://www.scopus.com/inward/record.url?scp=85098065107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098065107&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2020003304

DO - 10.1182/bloodadvances.2020003304

M3 - Letter

C2 - 33351114

AN - SCOPUS:85098065107

SN - 2473-9529

VL - 4

SP - 6199

EP - 6203

JO - Blood Advances

JF - Blood Advances

IS - 24

ER -

Accurate germline RUNX1 variant interpretation and its clinical significance

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this